Analystreport

Biohaven Ltd. (NYSE: BHVN) had its price target raised by analysts at Cantor Fitzgerald from $27.00 to $31.00.

Biohaven Ltd. Common Shares  (BHVN) 
Last biohaven ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com